Yahoo Web Search

Search results

  1. Jan 12, 2024 · Updated Jan. 12, 2024. Español. Print. What You Need to Know. There are two types of COVID-19 vaccines available in the United States: mRNA vaccines and protein subunit vaccines. CDC recommends the 2023–2024 updated COVID-19 vaccines: Pfizer-BioNTech, Moderna, or Novavax, to protect against serious illness from COVID-19.

  2. Nov 4, 2023 · Curious about how mRNA vaccines and other types of COVID-19 vaccines can help you develop immunity to the COVID-19 virus? Understand how different technologies work with the immune system to provide protection.

  3. Aug 31, 2022 · Immune Responses for Protection against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Current Covid-19 Vaccines. Early data from nonhuman primate studies showed the...

  4. The FDA issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus...

    Date
    Update
    Type
    11/01/2023
    Important Information About the Correct ...
    Press Release / Public Statement
    10/03/2023
    FDA Authorizes Updated Novavax COVID-19 ...
    Press Release / Public Statement
    9/11/2023
    FDA Takes Action on Updated mRNA COVID-19 ...
    Press Release / Public Statement
    6/16/2023
    Updated COVID-19 Vaccines for Use in the ...
    Press Release / Public Statement
  5. Apr 18, 2024 · Staying up to date with recommended COVID-19 vaccination protects nursing home residents against SARS-CoV-2 infection and associated severe outcomes (2,3). The Centers for Medicare & Medicaid Services (CMS) has required nursing homes to report SARS-CoV-2 infections among nursing home residents to CDC’s National Healthcare Safety Network (NHSN ...

  6. By the end of November 2021, scientists estimate that mRNA COVID-19 vaccines had prevented at least 1 million deaths, 10 million hospitalizations, and 36 million SARS-CoV-2 infections in the United States.

  7. Sep 23, 2020 · Development was initiated when the genetic sequence of the virus became available in early January 2020, and has moved at an unprecedented speed: a phase I trial started in March 2020 and there are...

  1. People also search for